Prevision Medicine is a Zurich-based precision-oncology company that brings functional precision medicine into clinical practice. Its PrevisionOne platform tests living cells from a patient's blood-cancer or solid-tumor biopsy against more than 100 oncology drugs and combinations and returns a ranked, patient-specific response report to the treating oncologist within days. The technique, known as pharmacoscopy, was co-invented by the company's R&D team at ETH Zurich and is validated in interventional clinical trials in hematological malignancies.
1
Round
1
Industry
4
Tags
Sep 24, 2026
Latest raise
Funding activity · 1 round
Sep 24, 2026
$5.4M
Seed
Led by ACE Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
